ETHAN - ET for Male BC
Conditions:   Male Breast Cancer;   Hormone Receptor-positive Breast Cancer;   Hormone Receptor Negative Breast Carcinoma Interventions:   Drug: Tamoxifen;   Drug: Anastrozole;   Drug: Degarelix;   Drug: Abemaciclib Sponsors:   Jose Pablo Leone;   Eli Lilly and Company;   Translational Breast Cancer Research Consortium (TBCRC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2022 Category: Research Source Type: clinical trials

Comparison of Adjuvant Monotherapy With Endocrine Therapy or Accelerated Partial Breast Irradiation Following Lumpectomy for Low Risk Breast Cancer Patients Over 65 (CAMERAN)
Conditions:   Breast Cancer;   Quality of Life Interventions:   Radiation: Accelerated Partial Breast Irradiation (APBI);   Drug: tamoxifen, anastrozole, exemestane, letrozole, fulvestrant, toremifene Sponsor:   UNC Lineberger Comprehensive Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2022 Category: Research Source Type: clinical trials